GlassScriptPhysician profile
Fred L Speck
NPI 1932337540
$10,498.66
in general payments reported to CMS, 2019-2025
35 companies · $1,162 in 2025
The $1,162 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,911 · 2020: $2,313 · 2021: $1,698 · 2022: $602 · 2023: $358 · 2024: $2,454 · 2025: $1,162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,258 · Food and Beverage: $1,716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,258.13 |
| Food and Beverage | $1,716.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,146.28 | 2019-2023 | Mako, Flexible Guide Pin (Stryker Acl Versitomic) |
| Corentec America INC | $2,187.18 | 2024 | |
| Medinc of Texas | $1,200.00 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $736.40 | 2020 | |
| Linvatec Corporation | $410.58 | 2025 | Biobrace 23mm |
| Sk Life Science, INC. | $252.71 | 2024-2025 | |
| Ucb, INC. | $189.73 | 2024-2025 | Briviact |
| Anika Therapeutics, INC. | $183.54 | 2025 | Tactoset |
| Depuy Synthes Sales INC. | $121.68 | 2019-2023 | Orthovisc, Monovisc |
| Harmony Biosciences LLC | $113.60 | 2024-2025 | |
| Horizon Therapeutics Plc | $101.85 | 2019-2022 | |
| Bioventus LLC | $82.01 | 2019-2022 | |
| Fidia Pharma USA INC. | $73.35 | 2020-2025 | Triluron, Hymovis |
| Biotissue Holdings INC. | $69.60 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $69.21 | 2022-2023 | Seglentis |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $65.87 | 2024-2025 | Amyvid, Kisunla |
| Abbvie INC. | $52.52 | 2022-2025 | |
| Pacira Pharmaceuticals Incorporated | $46.83 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $45.50 | 2024-2025 | Nuplazid |
| Assertio Therapeutics, INC. | $31.09 | 2020 | |
| Seaspine Orthopedics Corporation | $29.66 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.38 | 2024 | Hyqvia |
| Ethicon US, LLC | $26.60 | 2019-2021 | |
| Orthalign INC | $24.68 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $23.52 | 2024 | Nuedexta |
| Biogen, INC. | $21.39 | 2025 | Vumerity, Tysabri |
| Smith+Nephew, INC. | $21.36 | 2019 | |
| Amgen INC. | $20.28 | 2019 | |
| Abbott Laboratories | $19.86 | 2020 | |
| Next Science LLC | $18.30 | 2023 | Surgx, Blastx, Xperience |
| Trimed, INC. | $18.27 | 2020 | |
| Paratek Pharmaceuticals, INC. | $18.21 | 2025 | Nuzyra |
| Ermi LLC | $18.04 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.89 | 2019 | |
| Amneal Pharmaceuticals LLC | $15.69 | 2025 | Crexont |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Speck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.